Jul 31 |
Top 3 Health Care Stocks That May Explode In Q3
|
Jul 29 |
BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance
|
Jul 10 |
BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock
|
May 30 |
BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
|
May 30 |
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
|
May 21 |
BiomX (PHGE) Q1 2024 Earnings Call Transcript
|
May 21 |
BiomX GAAP EPS of -$0.28
|
May 21 |
BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates
|
May 15 |
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
|
Apr 29 |
BiomX files to sell 120.15M warrants for holders
|